LMAT vs XRAY
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
LMAT
38.7
AI Score
VS
XRAY Wins
XRAY
43.0
AI Score
Investment Advisor Scores
XRAY
43score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | LMAT | XRAY | Winner |
|---|---|---|---|
| Revenue | 164.15M | 2.61B | XRAY |
| Net Income | 32.85M | 25.00M | LMAT |
| Gross Margin | 68.4% | 52.1% | LMAT |
| Net Margin | 20.0% | 1.0% | LMAT |
| Operating Income | 39.40M | 84.00M | XRAY |
| ROE | 9.9% | 1.8% | LMAT |
| ROA | 8.7% | 0.5% | LMAT |
| Total Assets | 377.02M | 5.19B | XRAY |
| Cash | 21.00M | 195.00M | XRAY |
| Current Ratio | 7.74 | 1.63 | LMAT |
Relative Price Performance (Last 90 Days)
LMAT 1M: -3.4%
· 3M: -3.8%
XRAY 1M: +12.5%
· 3M: -17.4%
Current Technical Phase
LMAT
NeutralHold
Mixed signals - no dominant trend phase, RSI 42
XRAY
NeutralHold
Mixed signals - no dominant trend phase, RSI 50
Fundamentals Snapshot
| Metric | LMAT | XRAY |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.1 | 7.7 |
| Trailing P/E | 29.5 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | -0.1% |
| Gross Margin | 0.7% | 0.5% |
| Operating Margin | 0.3% | 0.0% |
| EPS | 2.75 | -0.61 |
| Dividend Yield | 0.01% | 0.02% |
Frequently Asked Questions
Based on our detailed analysis, XRAY is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.